Susan Bionat
Acute Care · Galveston, TXNPI 1861551681
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Abbott at 55.3% of the total. Reporting peaked in 2022 at $2,286 and has fallen 85.7% since, to $326 in 2025. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $38.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- AstraZeneca$356
- Novartis$329
- Amgen$278
- Impulse Dynamics (USA) Inc.$228
- Boehringer Ingelheim$214
- plus $1K from 14 others
What the payments were for
- Food & beverage$5,905100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 81 | $3,266 |
| AstraZeneca(2 entities) | 13 | $356 |
| Novartis | 6 | $329 |
| Amgen | 8 | $278 |
| Impulse Dynamics (USA) Inc. | 5 | $228 |
| Boehringer Ingelheim | 6 | $214 |
| Pfizer | 8 | $195 |
| Lexicon Pharmaceuticals, Inc. | 2 | $160 |
| AbbVie | 7 | $145 |
| Actelion Pharmaceuticals US, Inc. | 3 | $132 |
| ZOLL Circulation Inc | 1 | $129 |
| Bayer | 2 | $126 |
| Merck | 3 | $109 |
| Johnson & Johnson | 3 | $106 |
| Boston Scientific | 2 | $40 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $27 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Cvrx, Inc. | 1 | $18 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CardioMEMS HF System$620
- CARDIOMEMS$453
- OPTIMIZER$270
- ENTRESTO$226
- TherOx DS2 Console$129
- Catheter$129
- Downstream Cartridge$129
- Inpefa$112
- LEQVIO$107
How this compares
$5,910 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Furosemide | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other acute care in Galveston
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Bahia ElkamandSugar Land$23K
- Rachael SchneiderDallas$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.